Real possibility but these studies are always quite broad, and they would really have to see absolutely no affect described by the non placebo participants to arrive at a failure.
As always it would not just be bad for CANN but bad for the whole industry as this is probably one of the easier ones to get OTC approval for.
Interesting cannabis articles and worldwide updates., page-63
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.001(3.23%) |
Mkt cap ! $14.25M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.3¢ | 3.1¢ | $40.65K | 1.266M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1364238 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 400097 | 6 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| CAN (ASX) Chart |